Patent Assignment
Reel/Frame 063308/0475
Corrective Assignment to Correct the Patent Number 10622160 Should Be Patent Number 10662160 Previously Recorded at Reel: 063284 Frame: 0001. Assignor(S) Hereby Confirms the Assignment.
Recorded: 2023-04-12
Pages: 69
Assignor
BIOCRYST PHARMACEUTICALS, INC.
Executed: 2020-12-07
Assignee
ATHYRIUM OPPORTUNITIES III CO-INVEST 1 LP
505 FIFTH AVENUE, FLOOR 18, NEW YORK, NEW YORK, 10017
Covered Property
(1)
Crystalline Salts of a Plasma Kallikrein Inhibitor
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 17, 2019
From: EL-KATTAN, YAHYA; BABU, YARLAGADDA S.
To: BIOCRYST PHARMACEUTICALS, INC.
Reel/Frame 051304/0062 →
Security Interest
Apr 10, 2023
From: BIOCRYST PHARMACEUTICALS, INC.
To: ATHYRIUM OPPORTUNITIES III CO-INVEST 1 LP
Reel/Frame 063284/0001 →
Release of Grant of Security Interest in Patents
Apr 18, 2023
From: ATHYRIUM OPPORTUNITIES III CO-INVEST 1 LP
To: BIOCRYST PHARMACEUTICALS, INC.
Reel/Frame 063362/0550 →
Patent Security Agreement
Apr 19, 2023
From: BIOCRYST PHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 063363/0873 →
Termination and Release of Security Interest in Patent Collateral Recorded at Reel 063363/Frame 0873
Oct 8, 2025
From: BIOPHARMA CREDIT PLC
To: BIOCRYST PHARMACEUTICALS, INC.
Reel/Frame 073056/0492 →
Security Interest
Jan 23, 2026
From: BIOCRYST PHARMACEUTICALS, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 074485/0651 →